News
Kanazawa University and colleagues have achieved a breakthrough in understanding sperm DNA packaging. Using high-speed atomic ...
Researchers have uncovered answers that provide the detail to explain two specific DNA repair processes that have long been in question.
Researchers from the University of Birmingham have uncovered answers that provide the detail to explain two specific DNA ...
Researchers at Children's Hospital of Philadelphia (CHOP) developed a longitudinal atlas of neuroblastoma, a common and ...
Following CORDStrom TM, INmune Bio plans to transition production of INKmune ®, its NK-priming cell medicine for solid tumors, to the same facility, supporting ongoing and future trials in the US and ...
Kiji Therapeutics Engineered MSCs + IL-10 and CXCR4 offer tighter targeting and greater potency for challenging inflammatory diseases.
Chemokines, our body's chemical messengers, play a crucial role in regulating the immune response. They are secreted by ...
Cogent Biosciences, Inc. topline results for phase 2/3 studies on bezuclastinib targeting systemic mastocytosis & GIST are ...
Overproduction of fHbF and inadequate heme defence may contribute to foetal distress, suggests study
Authors evaluated the occurrence of cell free haemoglobin in the foetal circulation of severe early-onset foetal growth ...
A new study in the peer-reviewed journal Stem Cells and Development highlights the potential of mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) as a therapeutic strategy for high-dose ...
The Lupus Foundation of America (LFA) is excited to share that enrollment for the MiSLE (Mesenchymal Stromal Cells in ...
Blueprint Medicines Corporation focuses on Ayvakit, BLU-808, and Elenestinib with strong potential in mast cell disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results